The WTX tumor suppressor interacts with the transcriptional corepressor TRIM28

Journal of Biological Chemistry

Volumn 290, Issue 23, 2015, Pages 14381-14390

  Kim, Woo Jae ^a   Wittner, Ben S ^a   Amzallag, Arnaud ^a   Brannigan, Brian W ^a   Ting, David T ^a   Ramaswamy, Sridhar ^a   Maheswaran, Shyamala ^a   Haber, Daniel A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; CELL MEMBRANES; CYTOLOGY; ENCODING (SYMBOLS); MOBILE SECURITY; ONCOGENIC VIRUSES; STEM CELLS; TRANSCRIPTION;

CELLULAR DIFFERENTIATION; ENDOGENOUS RETROVIRUS; FUNCTIONAL INTERACTION; INTERSPERSED ELEMENTS; MOUSE EMBRYONIC STEM CELLS; OSTEOGENIC DIFFERENTIATION; PROTEIN-ENCODING GENES; WNT SIGNALING PATHWAYS;

TUMORS;

BETA CATENIN; COREPRESSOR PROTEIN; KRUPPEL LIKE FACTOR; REPETITIVE DNA; TRANSCRIPTIONAL COREPRESSOR TRIM28; UNCLASSIFIED DRUG; CHROMATIN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; TRIM28 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN; WTX PROTEIN, MOUSE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LONG INTERSPERSED REPEAT; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; RNA SEQUENCE; TUMOR SUPPRESSOR GENE; UPREGULATION; WTX GENE; ADIPOGENESIS; ANIMAL; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; NEPHROBLASTOMA; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ADIPOGENESIS; ANIMALS; CELL LINE; CHROMATIN; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; KIDNEY NEOPLASMS; MICE; NUCLEAR PROTEINS; PROTEIN INTERACTION MAPS; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS; WILMS TUMOR;

EID: 84930679145     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.631945     Document Type: Article

References (36)

1. Rivera, M. N., and Kim., W. J., Wells, J., Driscoll, D. R., Brannigan, B. W., Han, M., Kim, J. C., Feinberg, A.P., Gerald, W.L., and Vargas., S. O., Chin, L., Iafrate, A. J., Bell, D. W., and Haber, D. A. (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315, 642-645
2. Wegert, J., Wittmann, S., Leuschner, I., Geissinger, E., Graf, N., and Gessler, M. (2009) WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact. Genes Chromosomes Cancer 48, 1102-1111
3. Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337
4. Akhavanfard, S., and Vargas., S. O., Han, M., Nitta, M., Chang, C. B., Le, L. P., Fazlollahi, L., Nguyen, Q., Ma, Y., Cosper, A., Dias-Santagata, D., Han, J. Y., Bergethon, K., and Borger., D. R., Ellisen, L. W., Pomeroy, S. L., Haber, D. A., Iafrate, A. J., and Rivera, M. N. (2014) Inactivation of the tumor suppressor WTX in a subset of pediatric tumors. Genes Chromosomes Cancer 53, 67-77
5. Jenkins, Z. A., van Kogelenberg, M., Morgan, T., Jeffs, A., Fukuzawa, R., Pearl, E., Thaller, C., and Hing., A. V., Porteous, M. E., Garcia-Miñaur, S., Bohring, A., Lacombe, D., Stewart, F., Fiskerstrand, T., Bindoff, L., Berland, S., Adès, L. C., Tchan, M., David, A., Wilson, L. C., Hennekam, R. C., Donnai, D., Mansour, S., Cormier-Daire, V., and Robertson, S. P. (2009) Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat. Genet. 41, 95-100
6. Moisan, A., and Rivera., M. N., Lotinun, S., Akhavanfard, S., Coffman, E. J., Cook, E. B., Stoykova, S., Mukherjee, S., and Schoonmaker., J. A., Burger, A., Kim, W. J., Kronenberg, H. M., Baron, R., Haber, D. A., and Bardeesy, N. (2011) The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification. Dev. Cell 20, 583-596
7. Major, M. B., and Camp., N. D., Berndt, J. D., Yi, X., Goldenberg, S. J., Hubbert, C., Biechele, T. L., Gingras, A. C, Zheng, N, and Maccoss., M. J., Angers, S., and Moon, R. T. (2007) Wilms tumor suppressor WTX negatively regulates WNT/β-catenin signaling. Science 316, 1043-1046
8. Tanneberger, K., and Pfister., A. S., Brauburger, K., Schneikert, J., Hadjihannas, M. V., Kriz, V., Schulte, G., Bryja, V., and Behrens, J. (2011) Amer1/WTX couples Wnt-induced formation of PtdIns(4, 5)P2 to LRP6 phosphorylation. EMBOJ. 30, 1433-1443
9. Rivera, M. N, Kim, W. J., Wells, J., Stone, A., Burger, A., Coffman, E. J., Zhang, J., and Haber, D. A. (2009) The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity. Proc. Natl. Acad. Sci. U.S.A. 106, 8338-8343
10. Kim, W. J., and Rivera., M. N., Coffman, E. J., and Haber, D.A. (2012) The WTX tumor suppressor enhances p53 acetylation by CBP/p300. Mol. Cell 45, 587-597
11. Sripathy, S.P., Stevens, J., and Schultz, D. C. (2006) TheKAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression. Mol. Cell. Biol. 26, 8623-8638
12. Meerbrey, K. L., Hu, G., Kessler, J. D., Roarty, K., Li, M. Z., Fang, J. E., Herschkowitz, J. I., Burrows, A. E., Ciccia, A., Sun, T., Schmitt, E. M., Bernardi, R. J., Fu, X., Bland, C. S., Cooper, T. A., Schiff, R., Rosen, J. M., Westbrook, T. F., and Elledge, S. J. (2011) The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 108, 3665-3670
13. Ting, D. T., Lipson, D., Paul, S., Brannigan, B. W., Akhavanfard, S., Coffman, E. J., Contino, G., Deshpande, V., and Iafrate., A. J., Letovsky, S., Rivera, M. N, Bardeesy, N, Maheswaran, S., and Haber, D. A. (2011) Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 331, 593-596
14. Lipson, D., Raz, T., Kieu, A., Jones, D. R., Giladi, E., Thayer, E., and Thompson., J. F., Letovsky, S., Milos, P., and Causey, M. (2009) Quantification of the yeast transcriptome by single-molecule sequencing. Nat. Biotechnol. 27, 652-658
15. Wang, L., Feng, Z., Wang, X., Wang, X., and Zhang, X. (2010) DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26, 136-138
16. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., and Mesirov, J.P. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550
17. Cammas, F., Mark, M., Dollé, P., Dierich, A., Chambon, P., and Losson, R. (2000) Mice lacking the transcriptional corepressor TIF1 β are defective in early postimplantation development. Development 127, 2955-2963
18. Hu, G., Kim, J., Xu, Q., Leng, Y., and Orkin., S. H., and Elledge, S. J. (2009) A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 23, 837-848
19. Barde, I., Rauwel, B., Marin-Florez, R. M., Corsinotti, A., Laurenti, E., Verp, S., Offner, S., Marquis, J., Kapopoulou, A., Vanicek, J., and Trono, D. (2013) A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy. Science 340, 350-353
20. Weber, P., Cammas, F., Gerard, C, Metzger, D., Chambon, P., Losson, R., and Mark, M. (2002) Germ cell expression of the transcriptional co-repressor TIF1β is required for the maintenance of spermatogenesis in the mouse. Development 129, 2329-2337
21. Schultz, D. C, Friedman, J. R., and Rauscher, F. J., 3rd. (2001) Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2a subunit of NuRD. Genes Dev. 15, 428-443
22. Iyengar, S., and Farnham, P. J. (2011) KAP1 protein: an enigmatic master regulator of the genome. J. Biol. Chem. 286, 26267-26276
23. Ivanov, A. V., Peng, H., Yurchenko, V., Yap, K. L., Negorev, D. G., Schultz, D.C, Psulkowski, E., Fredericks, W.J., White, D.E., Maul, G.G., Sadofsky, M. J., Zhou, M. M., and Rauscher, F. J., 3rd. (2007) PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol. Cell 28, 823-837
24. Rowe, H. M., Jakobsson, J., Mesnard, D., Rougemont, J., Reynard, S., Aktas, T., Maillard, P. V., Layard-Liesching, H, Verp, S., Marquis, J., Spitz, F., Constam, D. B., and Trono, D. (2010) KAP1 controls endogenous retroviruses in embryonic stem cells. Nature 463, 237-240
25. Rodic, N, and Burns, K. H. (2013) Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms? PLoS Genet. 9, e1003402
26. Fazzio, T. G., and Huff., J. T., and Panning, B. (2008) An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134, 162-174
27. Tontonoz, P., and Spiegelman, B. M. (2008) Fat and beyond: the diverse biology of PPAR7. Annu. Rev. Biochem. 77, 289-312
28. Trosset, J. Y., Dalvit, C, Knapp, S., Fasolini, M., Veronesi, M., Mantegani, S., and Gianellini., L. M., Catana, C, Sundström, M., Stouten, P. F., and Moll, J. K. (2006) Inhibition of protein-protein interactions: the discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening. Proteins 64, 60-67
29. Farmer, S. R. (2006) Transcriptional control of adipocyte formation. Cell Metab. 4, 263-273
30. Zhang, Y., and Ng., H. H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13, 1924-1935
31. Baek, S. H. (2008) When ATPases pontin and reptin met telomerase. Dev. Cell 14, 459-461
32. Hohn, O., Hanke, K., and Bannert, N. (2013) HERV-K(HML-2), the best preserved family of HERVs: endogenization, expression, and implications in health and disease. Front. Oncol. 3, 246
33. Katoh, I., and Kurata, S. (2013) Association of endogenous retroviruses and long terminal repeats with human disorders. Front. Oncol. 3, 234
34. Filipponi, D., Muller, J., Emelyanov, A., and Bulavin, D. V. (2013) Wip1 controls global heterochromatin silencing via ATM/BRCA1-dependent DNA methylation. Cancer Cell 24, 528-541
35. Zhu, Q., and Pao., G. M., Huynh, A. M., Suh, H., Tonnu, N., and Nederlof., P. M., Gage, F. H., and Verma, I. M. (2011) BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477, 179-184
36. Singh, K., Cassano, M., Planet, E., Sebastian, S., and Jang., S. M., Sohi, G., Faralli, H., Choi, J., and Youn., H. D., Dilworth, F. J., and Trono, D. (2015) A KAP1 phosphorylation switch controls MyoD function during skeletal muscle differentiation. Genes Dev. 29, 513-525